(a) In the event that: the manufacturer submits to the State a ROSI (Reconciliation of State Invoice) form, the CMS-304 (OMB control number: 0938-0676), to the State, when a manufacturer notices a possible discrepancy with the data on the status of use of the medicinal products on the reduction invoice, that the manufacturer and the manufacturers declare in good faith that the printing page 12786 cannot be corrected before the due date of payment. When such a discrepancy is found for the invoice of a previous discount period, the manufacturer shall send the State a previous quarter adjustment form (PQAS), CMS-304a (OMB control number: 0938-0676). (i) “deposit price” means the price(s) available to each federal government deposit for the purchase of drugs by the manufacturer through the Supply Deposit System. The commenter asked CMS: to take additional steps to direct 340B of companies covered by the definition, in the Medicaid Managed Care context, of a single means for identifying 340B claims and to define specific procedures for states, Medicaid MCOs and companies covered by 340B, to ensure that 340B claims are excluded from the data transmitted to manufacturers to claim discounts. Because the 340B program is operated separately in accordance with federal law, states and security network providers must ensure that manufacturers do not pay double discounts for Medicaid recipients.27 Security network providers who are entitled to $340B discounts may choose to provide Medicaid recipients, According to state guidelines, drugs purchased with program discounts, and not 28.29 countries may require providers as Medicaid recipients: make the same decision for FFS and Managed Care participants in order to streamline drugs purchased with program discounts the procedure for determining claims eligible for discounts. . . .
The Most Trusted Coverage Service
